DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 52 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $127,000 | -93.5% | 44,002 | -86.8% | 0.00% | – |
| Q3 2016 | $1,967,000 | +107.7% | 334,603 | +6.0% | 0.00% | – |
| Q2 2016 | $947,000 | -72.8% | 315,722 | -51.5% | 0.00% | -100.0% |
| Q1 2016 | $3,488,000 | -54.5% | 650,704 | +0.8% | 0.00% | -50.0% |
| Q4 2015 | $7,662,000 | +137.7% | 645,510 | +64.4% | 0.00% | +100.0% |
| Q3 2015 | $3,224,000 | -41.8% | 392,716 | -1.1% | 0.00% | 0.0% |
| Q2 2015 | $5,541,000 | +119.6% | 397,184 | +278.3% | 0.00% | 0.0% |
| Q1 2015 | $2,523,000 | +48.5% | 104,989 | +1.7% | 0.00% | – |
| Q4 2014 | $1,699,000 | +50.9% | 103,184 | +16.6% | 0.00% | – |
| Q3 2014 | $1,126,000 | -43.2% | 88,469 | +0.6% | 0.00% | -100.0% |
| Q2 2014 | $1,984,000 | -27.3% | 87,901 | -9.0% | 0.00% | 0.0% |
| Q1 2014 | $2,730,000 | – | 96,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |